Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_assertion type Assertion NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_head.
- NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_assertion description "[Major signalling pathways that could play significant role in lung cancer therapy include (1) Growth promoting pathways (Epidermal Growth Factor Receptor/Ras/ PhosphatidylInositol 3-Kinase) (2) Growth inhibitory pathways (p53/Rb/P14ARF, STK11) (3) Apoptotic pathways (Bcl-2/Bax/Fas/FasL).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_provenance.
- NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_assertion evidence source_evidence_literature NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_provenance.
- NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_assertion SIO_000772 23276293 NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_provenance.
- NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_assertion wasDerivedFrom befree-2016 NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_provenance.
- NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_assertion wasGeneratedBy ECO_0000203 NP1039507.RAOIROa_FMY7ZUgSyNjpdV_4m628C3Sm9E8ZDi7-6laic130_provenance.